Lung fibrosis, more commonly referred to as pulmonary fibrosis, is generally a chronic and progressive lung disease where the tissues of the lungs thicken and become scarred. The scarring affects the ability of the lungs to function properly, thus making breathing hard and reducing the amount of oxygen taken in. If this continues, the lung tissue becomes stiff and hence less elastic, making it difficult for them to expand and contract efficiently. The exact cause of lung fibrosis can often elude, but several factors are known to cause it. It is caused by environmental pollutants that one may be exposed to over a long time, such as asbestos or dust; certain medications; and some medical treatments. It can also be caused by autoimmune conditions like rheumatoid arthritis and scleroderma. In many cases, it remains idiopathic, meaning it arises without a known cause. Although anybody can be affected, lung fibrosis is more common in those above the age of 50 years. It tends to occur more commonly in those who smoke or have occupational exposure to noxious substances. A family history of the same condition also may be a cause, as the role of some genetic factors in the development of the same is implicated. Treatment for lung fibrosis reinforces slowing down the advancement of the disease most of the time. Antifibrotics are medications that retard the scarring process and thereby help improve lung function. Pulmonary rehabilitation programs could also help patients cope better by providing exercise techniques to improve the management of symptoms. In severe cases, the patient may require oxygen therapy, and lung transplantation may be the last resort. Good management of this condition requires a healthcare provider who can work very closely with a patient to develop an individualized treatment plan for that patient. This certainly paves the way for better management of the condition and an improved quality of life.
Lung Fibrosis
